Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers
Laura Ceballos, Alejandro Krolewiecki, Marisa Juaréz, et al.
PLoS neglected tropical diseases (2018) Vol. 12, Iss. 1, pp. e0005945-e0005945
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Efficacy and Safety of Albendazole and High-Dose Ivermectin Coadministration in School-Aged Children Infected With Trichuris trichiura in Honduras: A Randomized Controlled Trial
Gabriela Matamoros, Ana Sánchez, José Antonio Gabrie, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 7, pp. 1203-1210
Open Access | Times Cited: 37
Repurposing of Benzimidazole Anthelmintic Drugs as Cancer Therapeutics
Bomi Song, Eun Young Park, Kwang Joon Kim, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4601-4601
Open Access | Times Cited: 27
Treatment of uncomplicated hepatic cystic echinococcosis (hydatid disease)
Rebecca Kuehn, Leonardo Uchiumi, Francesca Tamarozzi
Cochrane library (2024) Vol. 2024, Iss. 7
Open Access | Times Cited: 5
Development of Phytase Targeted PLGA Nanoparticles Loaded with Albendazole Sulfoxide and Praziquantel and Evaluation of Efficacy on the Hydatid Cysts
Yakup Gültekin, Çağla Korkmaz, Naile Öztürk, et al.
Journal of Drug Delivery Science and Technology (2025) Vol. 105, pp. 106662-106662
Closed Access
Pharmacokinetics of Albendazole, Albendazole Sulfoxide, and Albendazole Sulfone Determined from Plasma, Blood, Dried-Blood Spots, and Mitra Samples of Hookworm-Infected Adolescents
Jessica D. Schulz, Anna Neodo, Jean T. Coulibaly, et al.
Antimicrobial Agents and Chemotherapy (2019) Vol. 63, Iss. 4
Open Access | Times Cited: 32
High-Fat Breakfast Increases Bioavailability of Albendazole Compared to Low-Fat Breakfast: Single-Dose Study in Healthy Subjects
Dolores Ochoa, Miriam Saiz‐Rodríguez, Esperanza González‐Rojano, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 18
Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis
Charles Whittaker, Cédric B. Chesnais, Sébastien D. S. Pion, et al.
PLoS neglected tropical diseases (2022) Vol. 16, Iss. 10, pp. e0010497-e0010497
Open Access | Times Cited: 14
Combinations of the azaquinazoline anti-Wolbachia agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis
Shrilakshmi Hegde, Amy E. Marriott, Nicolas Pionnier, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Pharmacokinetics and tissue residues of albendazole sulphoxide and its metabolites in donkey after intramuscular injection
Zaijian Li, Xuling Qin, Changfa Wang, et al.
Veterinary Medicine and Science (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 2
Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d’Ivoire
Veshni Pillay-Fuentes Lorente, Jacinta N. Nwogu, Britta Steffens, et al.
Drugs in R&D (2024) Vol. 24, Iss. 2, pp. 331-340
Open Access | Times Cited: 2
Salting‐out homogeneous liquid‐liquid microextraction for the determination of azole drugs in human urine: Validation using total error concept
Natalia Manousi, Adamantia Vlachaki, Fotini S. Kika, et al.
Journal of Separation Science (2022) Vol. 45, Iss. 6, pp. 1240-1251
Closed Access | Times Cited: 9
Therapeutic efficacy of Albendazole and Mefloquine alone or in combination against early and late stages of Trichinella spiralis infection in mice
Azza Fahmy, T. Diab
Helminthologia (2021) Vol. 58, Iss. 2, pp. 179-187
Open Access | Times Cited: 11
Feeding Management and Albendazole Pharmacokinetics in Pigs
Alvarez Luis Ignacio, Chiappetta Valentina, Moriones Lucila, et al.
Animals (2023) Vol. 13, Iss. 3, pp. 474-474
Open Access | Times Cited: 4
Albendazole metabolites excretion in human saliva as a biomarker to assess treatment compliance in mass drug administration (MDA) anthelmintic programs
E. Nieves, Rubén O. Cimino, Alejandro Krolewiecki, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
In vivo pharmacokinetic study and PBPK modeling: Comparison between 3D-printed nanocrystals and solid dispersions
Lucía López-Vidal, Mariano Guillermo Tinti, María Elisa Melian, et al.
International Journal of Pharmaceutics (2024), pp. 125063-125063
Closed Access | Times Cited: 1
Nanotechnological Improvement of Veterinary Anthelmintics
Rodrigo Sanabria
Pharmaceutical Nanotechnology (2020) Vol. 9, Iss. 1, pp. 5-14
Closed Access | Times Cited: 11
Safety and effectiveness of delivering mass drug administration for helminths through the seasonal malaria chemoprevention platform among Senegalese children: study protocol for a randomised controlled trial
Muhammed O. Afolabi, Doudou Sow, Jean Louis Ndiaye, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 6
A molecularly imprinted polymer coupled with high-performance liquid chromatography-UV for the determination of albendazole in plasma and urine samples: CCD-RSM design
Hassan Abidi, Mehrorang Ghaedi, Abdollah Rafiei, et al.
New Journal of Chemistry (2018) Vol. 42, Iss. 19, pp. 15937-15945
Closed Access | Times Cited: 9
Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers
Jaime Algorta, Alejandro Krolewiecki, F. Pinto, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Improvement of Albendazole Bioavailability with Menbutone Administration in Sheep
Raquel Díez, M. José Diez, Juan J. García, et al.
Animals (2022) Vol. 12, Iss. 4, pp. 463-463
Open Access | Times Cited: 4
Population Pharmacokinetic Model of Oxfendazole and Metabolites in Healthy Adults following Single Ascending Doses
Thanh Bach, Daryl J. Murry, Larissa V. Stebounova, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 4
Open Access | Times Cited: 5
Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
Carl Boodman, Yashpal S. Chhonker, Daryl J. Murry, et al.
American Journal of Tropical Medicine and Hygiene (2018) Vol. 99, Iss. 5, pp. 1194-1197
Open Access | Times Cited: 4
Evaluation of immunodiagnostic tests for human gnathostomiasis using different antigen preparations of Gnathostoma spinigerum larvae against IgE, IgM, IgG, IgG1‐4 and IgG1 patterns of post‐treated patients
Issariya Ieamsuwan, Dorn Watthanakulpanich, Urai Chaisri, et al.
Tropical Medicine & International Health (2021) Vol. 26, Iss. 12, pp. 1634-1644
Open Access | Times Cited: 4
Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adults
Daniela Hofmann, Janneke M. Brussee, Jessica D. Schulz, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 77, Iss. 4, pp. 1082-1093
Closed Access | Times Cited: 3
Assessment of Diet-Related Changes on Albendazole Absorption, Systemic Exposure, and Pattern of Urinary Excretion in Treated Human Volunteers
Laura Ceballos, Elvia Nieves, Marisa Juaréz, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 9
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top